Terms: = Endocrine gland cancer AND NOTCH2, Q04721, 4853, ENSG00000134250, AGS2, hN2
40 results:
1. Anlotinib Inhibits Ovarian cancer and Enhances Cisplatinum Sensitivity
Xu X; Wang Q; Shen L; Shen Y; Liu H; Liu Y; Yang Z; Hoffman RM; Feng W
Anticancer Res; 2024 Apr; 44(4):1399-1407. PubMed ID: 38538004
[TBL] [Abstract] [Full Text] [Related]
2.
Chen B; Jiang K; Wang H; Miao L; Lin X; Chen Q; Jing L; Lu X
Front Biosci (Landmark Ed); 2023 Sep; 28(9):220. PubMed ID: 37796700
[TBL] [Abstract] [Full Text] [Related]
3. Clinical significance of Notch pathway-associated microRNA-107 in pancreatic ductal adenocarcinoma.
Rashid S; Rashid S; Das P; Singh N; Dash NR; Nayak B; Sati HC; Chauhan SS; Gupta S; Saraya A
Future Oncol; 2023 May; 19(14):1003-1012. PubMed ID: 37199277
[No Abstract] [Full Text] [Related]
4. MTHFD1L knockdown diminished cells growth in papillary thyroid cancer.
Yi D; Yilihamu Y; Jiang C; Wang R; Lu X; Sang J; Su L
Tissue Cell; 2022 Aug; 77():101869. PubMed ID: 35870426
[TBL] [Abstract] [Full Text] [Related]
5. Preoperative biliary drainage in severely jaundiced patients with pancreatic head cancer: A retrospective cohort study.
van Gils L; Verbeek R; Wellerdieck N; Bollen T; van Leeuwen M; Schwartz M; Vleggaar F; Molenaar IQQ; van Santvoort H; van Hooft J; Verdonk R; Weusten B;
HPB (Oxford); 2022 Nov; 24(11):1888-1897. PubMed ID: 35803831
[TBL] [Abstract] [Full Text] [Related]
6. The role of Jagged1 as a dynamic switch of cancer cell plasticity in PDAC assembloids.
Choi JI; Rim JH; Jang SI; Park JS; Park H; Cho JH; Lim JB
Theranostics; 2022; 12(9):4431-4445. PubMed ID: 35673567
[No Abstract] [Full Text] [Related]
7. Impact of endocrine and Exocrine Insufficiency on Quality of Life After Total Pancreatectomy.
Stoop TF; Ateeb Z; Ghorbani P; Scholten L; Arnelo U; Besselink MG; Del Chiaro M
Ann Surg Oncol; 2020 Feb; 27(2):587-596. PubMed ID: 31562603
[TBL] [Abstract] [Full Text] [Related]
8. A randomized phase II trial of nab-paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer.
Hu ZI; Bendell JC; Bullock A; LoConte NK; Hatoum H; Ritch P; Hool H; Leach JW; Sanchez J; Sohal DPS; Strickler J; Patel R; Wang-Gillam A; Firdaus I; Yu KH; Kapoun AM; Holmgren E; Zhou L; Dupont J; Picozzi V; Sahai V; O'Reilly EM
Cancer Med; 2019 Sep; 8(11):5148-5157. PubMed ID: 31347292
[TBL] [Abstract] [Full Text] [Related]
9. Role of Jagged1/STAT3 signalling in platinum-resistant ovarian cancer.
Yang J; Xing H; Lu D; Wang J; Li B; Tang J; Gu F; Hong L
J Cell Mol Med; 2019 Jun; 23(6):4005-4018. PubMed ID: 30993885
[TBL] [Abstract] [Full Text] [Related]
10. Attenuation of MAMLD1 Expression Suppresses the Growth and Migratory Properties of Gonadotroph Pituitary Adenomas.
Qi J; Ni W
Pathol Oncol Res; 2020 Apr; 26(2):937-946. PubMed ID: 30911995
[TBL] [Abstract] [Full Text] [Related]
11. Dendrimer-paclitaxel complexes for efficient treatment in ovarian cancer: study on OVCAR-3 and HEK293T cells.
Yao H; Ma J
Acta Biochim Pol; 2018; 65(2):219-225. PubMed ID: 29913480
[TBL] [Abstract] [Full Text] [Related]
12. Notch-Induced Myeloid Reprogramming in Spontaneous Pancreatic Ductal Adenocarcinoma by Dual Genetic Targeting.
Cheung PF; Neff F; Neander C; Bazarna A; Savvatakis K; Liffers ST; Althoff K; Lee CL; Moding EJ; Kirsch DG; Saur D; Bazhin AV; Trajkovic-Arsic M; Heikenwalder MF; Siveke JT
Cancer Res; 2018 Sep; 78(17):4997-5010. PubMed ID: 29844119
[TBL] [Abstract] [Full Text] [Related]
13. Notch pathway inhibition targets chemoresistant insulinoma cancer stem cells.
Capodanno Y; Buishand FO; Pang LY; Kirpensteijn J; Mol JA; Argyle DJ
Endocr Relat Cancer; 2018 Feb; 25(2):131-144. PubMed ID: 29175872
[TBL] [Abstract] [Full Text] [Related]
14. Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer.
Imamura T; Komatsu S; Ichikawa D; Miyamae M; Okajima W; Ohashi T; Kiuchi J; Nishibeppu K; Konishi H; Shiozaki A; Morimura R; Ikoma H; Ochiai T; Okamoto K; Taniguchi H; Otsuji E
Sci Rep; 2017 Jul; 7(1):5708. PubMed ID: 28720759
[TBL] [Abstract] [Full Text] [Related]
15. EGFL7 participates in regulating biological behavior of growth hormone-secreting pituitary adenomas via notch2/DLL3 signaling pathway.
Wang J; Liu Q; Gao H; Wan D; Li C; Li Z; Zhang Y
Tumour Biol; 2017 Jul; 39(7):1010428317706203. PubMed ID: 28705113
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic roles of Notch receptor mRNA expression in human ovarian cancer.
Chen C; Wang X; Huang S; Wang L; Han L; Yu S
Oncotarget; 2017 May; 8(20):32731-32740. PubMed ID: 28415574
[TBL] [Abstract] [Full Text] [Related]
17. Immune Cytolytic Activity Stratifies Molecular Subsets of Human Pancreatic cancer.
Balli D; Rech AJ; Stanger BZ; Vonderheide RH
Clin Cancer Res; 2017 Jun; 23(12):3129-3138. PubMed ID: 28007776
[No Abstract] [Full Text] [Related]
18. The Clinical Significance of miR-34a in Pancreatic Ductal Carcinoma and Associated Molecular and Cellular Mechanisms.
Long LM; Zhan JK; Wang HQ; Li S; Chen YY; Liu YS
Pathobiology; 2017; 84(1):38-48. PubMed ID: 27458977
[TBL] [Abstract] [Full Text] [Related]
19. Targeted next generation sequencing of endoscopic ultrasound acquired cytology from ampullary and pancreatic adenocarcinoma has the potential to aid patient stratification for optimal therapy selection.
Gleeson FC; Kerr SE; Kipp BR; Voss JS; Minot DM; Tu ZJ; Henry MR; Graham RP; Vasmatzis G; Cheville JC; Lazaridis KN; Levy MJ
Oncotarget; 2016 Aug; 7(34):54526-54536. PubMed ID: 27203738
[TBL] [Abstract] [Full Text] [Related]
20. Differential Expression of Stem Cell Markers in Human Adamantinomatous Craniopharyngioma and Pituitary Adenoma.
Chang CV; Araujo RV; Cirqueira CS; Cani CM; Matushita H; Cescato VA; Fragoso MC; Bronstein MD; Zerbini MC; Mendonca BB; Carvalho LR
Neuroendocrinology; 2017; 104(2):183-193. PubMed ID: 27161333
[TBL] [Abstract] [Full Text] [Related]
[Next]
